P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL
Main Authors: | Y. Song, J. Jin, H. Tilly, H. Zhang, J. Cao, J. Feng, L. Zhang, S. Rai, H. Goto, Y. Terui, W. S. Kim, H.-J. Shin, J.-P. Gau, C.-H. Tsai, J. P. Sharman, L. Bu, J. Hirata, C. Lee, K. Izutsu, J. Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847632.22579.29 |
Similar Items
-
P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY
by: M. Trněný, et al.
Published: (2022-06-01) -
P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL
by: F. Morschhauser, et al.
Published: (2022-06-01) -
Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX
by: Michael Z. Liao, et al.
Published: (2023-12-01) -
Dlaczego rok 1192 stał się początkiem historii miasta Czarnkowa?
by: Wojciech Nowacki
Published: (2010-12-01) -
Correction to Lancet Glob Health 2017; 5: e1192–207
Published: (2018-01-01)